- Home
- ATUS vs NUVB Comparison
ATUS vs NUVB Comparison
Compare ATUS & NUVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATUS
- NUVB
- Stock Information
- Founded
- ATUS 2015
- NUVB 2018
- Country
- ATUS United States
- NUVB United States
- Employees
- ATUS N/A
- NUVB N/A
- Industry
- ATUS Cable & Other Pay Television Services
- NUVB Biotechnology: Pharmaceutical Preparations
- Sector
- ATUS Telecommunications
- NUVB Health Care
- Exchange
- ATUS Nasdaq
- NUVB Nasdaq
- Market Cap
- ATUS 1.1B
- NUVB 1.1B
- IPO Year
- ATUS 2017
- NUVB N/A
- Fundamental
- Price
- ATUS $2.70
- NUVB $3.72
- Analyst Decision
- ATUS Hold
- NUVB Strong Buy
- Analyst Count
- ATUS 6
- NUVB 7
- Target Price
- ATUS $2.88
- NUVB $8.43
- AVG Volume (30 Days)
- ATUS 4.3M
- NUVB 6.7M
- Earning Date
- ATUS 11-06-2025
- NUVB 11-05-2025
- Dividend Yield
- ATUS N/A
- NUVB N/A
- EPS Growth
- ATUS N/A
- NUVB N/A
- EPS
- ATUS N/A
- NUVB N/A
- Revenue
- ATUS $8,762,212,000.00
- NUVB $14,355,000.00
- Revenue This Year
- ATUS N/A
- NUVB $332.80
- Revenue Next Year
- ATUS N/A
- NUVB $360.12
- P/E Ratio
- ATUS N/A
- NUVB N/A
- Revenue Growth
- ATUS N/A
- NUVB 900.35
- 52 Week Low
- ATUS $1.95
- NUVB $1.54
- 52 Week High
- ATUS $3.20
- NUVB $4.09
- Technical
- Relative Strength Index (RSI)
- ATUS 56.69
- NUVB 61.28
- Support Level
- ATUS $2.35
- NUVB $3.52
- Resistance Level
- ATUS $2.63
- NUVB $3.88
- Average True Range (ATR)
- ATUS 0.13
- NUVB 0.22
- MACD
- ATUS 0.01
- NUVB 0.01
- Stochastic Oscillator
- ATUS 56.25
- NUVB 67.02
About ATUS Altice USA Inc.
Altice Europe acquired privately held US cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink's networks provide television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York.
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.